Skip to main content

B-cell Malignancy clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • Expansion Study of BGB-16673 in Patients With B-Cell Malignancies

    open to eligible people ages 18 years and up

    Study consists of two main parts to explore BGB-16673 recommended dosing, a part 1 monotherapy dose finding comprised of monotherapy dose finding and monotherapy safety expansion of selected doses, and a part 2 (cohort expansion cohorts)

    La Jolla, California and other locations

Last updated: